Market News & Trends
Acquisition Acquisition Creates Most Robust Rare Disease Pipeline in Biotech
Alexion Pharmaceuticals, Inc. and Synageva BioPharma Corp. recently announced they have entered into a definitive agreement pursuant to which Alexion will acquire Synageva for consideration…
Xcelience CEO & President Named Finalist in Entrepreneur of The Year 2015 Awards
Xcelience's Derek Hennecke has been named a finalist in the EY Entrepreneur Of The Year 2015 Florida Awards. Mr. Hennecke was selected from more than…
Recombinant & Prophylactic Treatments Boost Global Haemophilia Therapeutics Market
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are…
Alzheimer's Disease Treatment Market Value Will Exceed $13 Billion
The global market for Alzheimer’s Disease (AD) treatment will more than double in value from $4.9 billion in 2013 to reach an estimated $13.3 billion…
Celgene to Acquire Biotech Company
Celgene Corporation and Quanticel Pharmaceuticals, Inc. recently announced a definitive share purchase agreement under which Celgene Corporation will acquire Quanticel. Through the agreement, Celgene will…
EMD Millipore Introduces Kits for the Analysis of Chromatin-Associated RNAs
EMD Millipore recently introduced Magna ChIRP RNA Interactome Kits, which allow researchers to more easily identify, recover, and analyze regions of chromatin that interact with…
Vetter Serializes the First Product for South Korea
Vetter recently announced the manufacture of the first commercial batches with single-use identification numbers. Following the introduction of a comprehensive serialization service last year, the…
Exco InTouch Predicts Substantial Growth in Device Integration
Exco InTouch predicts a substantial increase in device integration in clinical trials and real-world programs in 2015 and beyond. Device integration has proved highly beneficial,…
Innate Pharma and AstraZeneca Announce Global Agreement
Innate Pharma SA recently announced that it has signed a co-development and commercialization agreement with AstraZeneca, along with MedImmune, its global biologics research and development…
Clover Oncology Receives Breakthrough Therapy Designation
Clovis Oncology, Inc. recently announced the US FDA has granted Breakthrough Therapy designation for the company’s investigational agent rucaparib as monotherapy treatment of advanced ovarian…
CMOCRO: Intuitive Platform Provides Quick Access to Global Database of Pharmaceutical Suppliers, Supports Partnering Decisions
By: Ashish Shukla, PhD CMOCRO is an intuitive platform designed to quickly access a global database of pharmaceutical suppliers, and aims to support…
Generex Announces New $11-Million Collaboration
Generex Biotechnology Corporation recently announced that it has entered into a non-binding Letter of Intent (LOI) to license the Generex proprietary RapidMis drug delivery technologies…
Investigational Brain Cancer Vaccine Produces Strong Immunological Response
A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a…
Dicerna Presents New Data From Multiple Tumor Models
Dicerna Pharmaceuticals, Inc. recently announced promising new in vivo data for CTNNB1 DsiRNA in multiple patient-derived xenograft (PDX) and other models of diverse tumor types.…
Huntingdon Life Sciences & Harlan Laboratories Announce Significant Launch
Huntingdon Life Sciences and Harlan Laboratories recently announced the launch of the SHrN – the world’s first hairless NOD.SCID mouse model to reach the market.…
Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline
Deciphera Pharmaceuticals recently announced that preclinical data on the company’s growing pipeline of next-generation kinase inhibitors were presented at the American Association for Cancer Research…
BIND Therapeutics Presents Positive Data Highlighting Ability of Accurins
BIND Therapeutics, Inc. recently announced that clinical and preclinical data from its oncology pipeline, including proprietary and collaboration programs, were presented at the American Association…
Ease the Path To Biosimilars Approval
Biosimilars Market Exploding! Do You Know FDA Requirements? Successful 351(k) Biosimilar Applications When it comes to FDA approval for biosimilars, the devil is in the…
EMA Endorses Development of Generic Topicals
European regulators are looking to industry for suggestions on the best ways to get generic versions of topical drugs approved without having to conduct time-consuming…
Gx MultiShell Unites the Properties of Glass & Plastic
Every day, millions of people are treated with parenteral medications, such as precautionary vaccinations or injections and infusions for medical conditions. Gerresheimer supplies the pharmaceutical…
2025 - 5 - Gattefosse - 250x250